Oncology - New method uncovers how extracellular vesicles impact immune response in cancer
View as a Web Page
News Medical
 
  Oncology Oncology logo  
  The latest oncology news from News Medical  
 

Meet the Next Evolution of ddPCR SolutionsMeet the Next Evolution of ddPCR Solutions

Introducing Bio-Rad's most advanced Droplet Digital™ PCR (ddPCR™) systems yet — the QX Continuum™ and QX700™ systems series, which set new standards in sensitivity, workflow simplicity, ease of multiplexing, and performance through absolute quantification.

Discover More
 
   New method uncovers how extracellular vesicles impact immune response in cancerNew method uncovers how extracellular vesicles impact immune response in cancer
 
Certain types of biochemical processes can impair the immune system's ability to recognize and kill cancer cells. Purdue University's W. Andy Tao and his associates have developed a new way to study these processes.
 
   Study finds minimal risk of second cancer in breast cancer survivorsStudy finds minimal risk of second cancer in breast cancer survivors
 
For women diagnosed with early breast cancer, the long-term risk of developing a second primary cancer is low (around 2-3% greater than women in the general population), finds a study published by The BMJ today.
 
 ESC releases new guidance on lipid management to reduce cardiovascular risk
 
ESC releases new guidance on lipid management to reduce cardiovascular riskNew ESC/EAS Focused Update to Guidelines, about how best to manage lipid levels in patients to reduce cardiovascular risk, recommends the use of new cardiovascular risk predication algorithms. The update was published today at ESC Congress 2025.
 
 
 Disrupting protein quality control slows tumor growth in pediatric rhabdomyosarcoma
 
Disrupting protein quality control slows tumor growth in pediatric rhabdomyosarcomaA new research paper was published in Volume 16 of Oncotarget on August 29, 2025, titled "In vivo manipulation of the protein homeostasis network in rhabdomyosarcoma."
 
 
 RNA Binding Proteins and EVs Offer Clues to Cancer's Evasion of Immune Response
 
RNA Binding Proteins and EVs Offer Clues to Cancer's Evasion of Immune ResponseCertain types of biochemical processes can impair the immune system's ability to recognize and kill cancer cells. Purdue University's W. Andy Tao and his associates have developed a new way to study these processes.
 
 
 The role of transcription factors in next-gen drug discovery
 
The role of transcription factors in next-gen drug discoveryDiscover how transcription factors are revolutionizing drug discovery.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2025